Netarsudil as an Adjunctive Therapy: Efficacy and Factors Contributing to a Favorable IOP-Lowering Effect

Figure 3

Stacked bar charts for percent IOP reduction from baseline across all patients, number of agents, baseline IOP category, and by the responder type. (a) Percent IOP reduction across all patients. (b) Percent IOP reduction by the number of agents. (c) Percent IOP reduction by the baseline IOP category. (d) Percent IOP reduction by the responder type.

(a)

(b)

(c)

(d)